Boehringer Sues Drugmakers To Block Generic Gilotrif Plans
German drugmaker Boehringer Ingelheim Pharmaceuticals Inc. filed a pair of patent infringement suits Friday in New Jersey federal court over bids by Sandoz Inc. and Sun Pharmaceutical Industries to market generic...To view the full article, register now.
Already a subscriber? Click here to view full article